Subscribe To
Verona's ensifentrine: a promising novel treatment for copd patients
Verona Pharma's ensifentrine is a first-in-class, inhaled, dual inhibitor of the enzymes PDE3 and PDE4, target...
March 27, 2023, 2:31 am
Genelux: recent ipo with phase 3 stage oncolytic virus cancer therapy
GNLX IPO-ed recently, but the company has been around for two decades. The company develops an oncolytic virus...
March 26, 2023, 10:50 pm
Ideaya biosciences has a strong pipeline and looks investible
IDEAYA Biosciences, Inc.'s platform is synthetic lethality targeting cancer. The company has produced s...
March 24, 2023, 4:24 pm
Rocket lab targets $50 million launch price for neutron rocket to challenge spacex's falcon 9
Rocket Lab is targeting a $50 million launch price for its coming reusable launch vehicle called Neutro...
March 24, 2023, 3:57 pm
Hindenburg targets block, erasing more than $6.5 billion in market cap
CNBC's MacKenzie Sigalos reports on the market reaction to Hindenburg's latest report, this time targeting ...
March 24, 2023, 7:19 am
Options traders targeting 3 moving stocks today
Stocks are rebounding as Wall Street continues to unpack yesterday's interest rate hike, with investors considering the Fed's policy for the rest of t...
March 23, 2023, 2:58 pm
Bombardier shares take off as jet maker ups 2025 targets
Bombardier (TSX:BBD.B) shares have taken flight after the Montreal, Canada-based business jet manufacturer announced it is...
March 23, 2023, 10:19 am
Rakuten group to test market with public offer of banking arm
Japanese e-commerce giant Rakuten Group Inc (OTC:RKUNF) will test the market with public offer on the Tokyo stock exchange of its banking arm next mon...
March 22, 2023, 10:22 am
Facebook political microtargeting at center of gdpr complaints in germany
In its latest piece of strategic litigation, the precision-punching European privacy rights campaign group noyb has used data donated by users of the ...
March 21, 2023, 2:00 am
Meta pivoting to focus on ai ‘that will help with the ad targeting': analyst
Edward Jones Senior Equity Analyst David Heger details Meta's latest round of layoffs, its position in the digital advertising market, and its refocus...
March 20, 2023, 5:28 pm
Mirati's krazati: a strong competitor in the kras g12c-mutated nsclc market
Mirati Therapeutics specializes in developing cancer treatments targeting genetic and immunological cau...
March 20, 2023, 3:43 am
Brookfield infrastructure: a resolute 4.8% yield in these trying times
Brookfield Infrastructure Partners is paying out a 4.8% yield from a portfolio of highly cash-generative essential infrastructure assets. Fiscal 2022 ...
March 16, 2023, 9:18 pm
Is it too late to buy ulta beauty stock?
Sales are holding up well and margins are increasing. Ulta Beauty is targeting another year of solid re...
March 16, 2023, 10:15 am
Japan gold kicks off drilling at barrick alliance mizobe project in southern kyushu
Japan Gold (TSX-V:JG) Corp has announced the start of drilling at the Barrick Alliance Mizobe Project in southern Kyushu, Japan, which is one of six p...
March 16, 2023, 9:57 am
Warren buffett loads up on occidental stock as energy stocks plummet
Warren Buffett is targeting Occidental Petroleum share prices no higher than $62. The post Warren Buffe...
March 16, 2023, 9:33 am
Dollar tree: margin concerns and fair valuation
Economic conditions have both helped and hindered Dollar tree, with sales increasing but volume declining. DLTR is inherently a defensive bet,...
March 16, 2023, 4:06 am
Facebook's behavioral ads lacked legal basis, dutch court rules
In the latest blow to Meta's consentless behavioral ad-targeting business in Europe, a Dutch court has found the social media giant's Irish subsidiary...
March 15, 2023, 12:22 pm
7 biotech stocks that could be the next big thing
While the concept of high-risk speculation seems particularly dangerous at this juncture, gamblers may nevertheless want to consider the merits of
March 15, 2023, 11:44 am
Oric pharma: small pfizer deal, cash, and a set of very early stage assets
ORIC has a few early stage cancer targeting molecules. In December, Pfizer made a small $25mn deal with...
March 15, 2023, 12:47 am
Volkswagen: still targeting an affordable ev by 2025
Volkswagen still wants to bring an affordable electric vehicle - costing around 25,000 euros ($26,790.00) in today's prices - to market by 2025, the c...
March 14, 2023, 7:24 am